For example, in a phase II clinical study on immunotherapy of pancreatic cancer, although 12% of patients had high PD-L1 expression (more than 25% of tumor cells expressed PD-L1), However, PD-L1 inhibitor therapy did not achieve ideal objective remission rate 15. The gene discussed is CD274; the disease is pancreatic neoplasm.